Bone Metastases Result in Worse Outcomes for RCC Patients

Bone metastases result in poorer outcomes for those patients with advanced renal cell carcinoma (RCC), who were treated with a molecularly targeted therapy. The results were presented in two separate analyses at the annual ASCO meeting.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news